Some doctors have suspected that Alzheimer's disease patients could be saved if the plaque that builds up in their brains could be removed, but a new vaccine that did just that suggests the theory is wrong. British researchers...
LONDON, July 18 (UPI) -- A potential new weapon against Alzheimer's is nothing to sneeze at because it's a hay fever medication, British doctors said. The antihistamine dimebon improved brain function and memory in patients...
LONDON, July 18 (UPI) -- A potential new weapon against Alzheimer's is nothing to sneeze at because it's a hay fever medication, British doctors said. The antihistamine dimebon improved brain function and memory in patients...
LONDON, July 18 (UPI) -- A potential new weapon against Alzheimer's is nothing to sneeze at because it's a hay fever medication, British doctors said. The antihistamine dimebon improved brain function and memory in patients...
A potential new weapon against Alzheimer's is nothing to sneeze at because it's a hay fever medication, British doctors said.The antihistamine dimebon improved brain function and memory in patients with early- to mid-stage...
By Steven Reinberg HealthDay Reporter 7 minutes ago FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease. In one of two studies in the July 19 issue...
By Steven Reinberg HealthDay Reporter 53 minutes ago FRIDAY, July 18 (HealthDay News) -- It's one step forward, one step back in the search for treatments against Alzheimer's disease. In one of two studies in the July 19 issue...
CHICAGO (Reuters) - A new drug showed promise at treating Alzheimer's disease, but an experimental vaccine that cleared brain-clogging plaques failed to improve memory or help patients live longer, researchers said on Thursday....
Dimebon - the drug first discovered in 1983 and sold in Russia as an antihistamine - significantly improves the clinical course of patients with Alzheimer's disease, according to a study published in The Lancet. "More research...
A new study discovers a drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer’s disease. Experts from Baylor College of Medicine in Houston publish their...